Targeting ribonucleotide reductase for cancer therapy

Expert Opinion on Therapeutic Targets - Tập 17 Số 12 - Trang 1423-1437 - 2013
Jimin Shao1, Xiyong Liu2,3, Lijun Zhu1, Yun Yen2,3
1Zhejiang University, School of Medicine, Department of Pathology and Pathophysiology, Hangzhou 310058, China
2+1 626 471 3607
3Beckman Research Institute, Department of Molecular Pharmacology, City of Hope National Medical Center, 1500 E. Duarte Rd, Duarte, CA 91010, USA +1 626 256 4673 ext 65707

Tóm tắt

Từ khóa


Tài liệu tham khảo

Nordlund P, 2006, Annu Rev Biochem, 75, 681, 10.1146/annurev.biochem.75.103004.142443

Cotruvo JA, 2011, Annu Rev Biochem, 80, 733, 10.1146/annurev-biochem-061408-095817

Andersson KK, 2008, Hauppauge

Kolberg M, 2004, Biochim Biophys Acta, 1699, 1, 10.1016/S1570-9639(04)00054-8

Nocentini G, 1996, Crit Rev Oncol Hematol, 22, 89, 10.1016/1040-8428(95)00187-5

Smith BD, 2003, Leuk Res, 27, 1075, 10.1016/S0145-2126(03)00248-0

Shao J, 2006, Curr Cancer Drug Targets, 6, 409, 10.2174/156800906777723949

Uhlin U, 1994, Nature, 370, 533, 10.1038/370533a0

Nordlund P, 1990, Nature, 345, 593, 10.1038/345593a0

Nordlund P, 1993, J Mol Biol, 232, 123, 10.1006/jmbi.1993.1374

Ando N, 2011, Proc Natl Acad Sci USA, 108, 21046, 10.1073/pnas.1112715108

Tanaka H, 2000, Nature, 404, 42, 10.1038/35003506

Kauppi B, 1996, J Mol Biol, 262, 706, 10.1006/jmbi.1996.0546

Strand KR, 2004, J Biol Chem, 279, 46794, 10.1074/jbc.M407346200

Smith P, 2009, Biochemistry, 48, 11134, 10.1021/bi9001425

Fairman JW, 2011, Nat Struct Mol Biol, 18, 316, 10.1038/nsmb.2007

Stubbe J, 2003, Chem Rev, 103, 2167, 10.1021/cr020421u

Blomberg MR, 2006, Biochim Biophys Acta, 1757, 969, 10.1016/j.bbabio.2006.01.002

Reece SY, 2009, Annu Rev Biochem, 78, 673, 10.1146/annurev.biochem.78.080207.092132

Narvaez AJ, 2006, J Biol Chem, 281, 26022, 10.1074/jbc.M604598200

Guittet O, 2001, J Biol Chem, 276, 40647, 10.1074/jbc.M106088200

Tomter AB, 2012, PLoS One, 7, e33436, 10.1371/journal.pone.0033436

Shao J, 2004, Cancer Res, 64, 1, 10.1158/0008-5472.CAN-03-3048

Hofer A, 2012, Crit Rev Biochem Mol Biol, 47, 50, 10.3109/10409238.2011.630372

Brissenden JE, 1988, Exp Cell Res, 174, 302, 10.1016/0014-4827(88)90165-6

Yang-Feng TL, 1987, Genomics, 1, 77, 10.1016/0888-7543(87)90108-X

10.1021/bi00475a007

Liu X, 2004, Biochem Pharmacol, 67, 1499, 10.1016/j.bcp.2003.12.026

Chabes AL, 2003, Proc Natl Acad Sci USA, 100, 3925, 10.1073/pnas.0330774100

Chabes AL, 2004, J Biol Chem, 279, 10796, 10.1074/jbc.M312482200

D'Angiolella V, 2012, Cell, 149, 1023, 10.1016/j.cell.2012.03.043

Hakansson P, 2006, J Biol Chem, 281, 7834, 10.1074/jbc.M512894200

Chang L, 2008, Proc Natl Acad Sci USA, 105, 18519, 10.1073/pnas.0803313105

Kimura T, 2003, Nat Genet, 34, 440, 10.1038/ng1212

Bourdon A, 2007, Nat Genet, 39, 776, 10.1038/ng2040

Lozano G, 2000, Nature, 404, 24, 10.1038/35003670

Thelander L, 2007, Nat Genet, 39, 703, 10.1038/ng0607-703

Zhou B, 2003, Cancer Res, 63, 6583

Kashlan OB, 2003, Biochemistry, 42, 1696, 10.1021/bi020634d

10.1080/15257770.2011.644370

Zimanyi CM, 2012, Structure, 20, 1374, 10.1016/j.str.2012.05.009

Rofougaran R, 2006, J Biol Chem, 281, 27705, 10.1074/jbc.M605573200

Engstrom Y, 1984, Embo J, 3, 863, 10.1002/j.1460-2075.1984.tb01897.x

Reddy GP, 1993, Crit Rev Eukaryot Gene Expr, 3, 255

Xue L, 2003, Cancer Res, 63, 980

Niida H, 2010, Genes Dev, 24, 333, 10.1101/gad.1863810

Zhang YW, 2009, J Biol Chem, 284, 18085, 10.1074/jbc.M109.003020

Liu X, 2005, Biochem Pharmacol, 70, 1288, 10.1016/j.bcp.2005.08.005

Pontarin G, 2008, Proc Natl Acad Sci USA, 105, 17801, 10.1073/pnas.0808198105

Wu X, 2008, Mol Cell Biol, 28, 7156, 10.1128/MCB.01388-08

Fontecave M, 1989, J Biol Chem, 264, 9164, 10.1016/S0021-9258(18)60509-5

Hurta RA, 1991, Biochem Cell Biol, 69, 635, 10.1139/o91-094

Sanvisens N, 2013, Biomed J, 36, 51, 10.4103/2319-4170.110398

Salguero I, 2012, Curr Biol, 22, 720, 10.1016/j.cub.2012.02.070

Fan H, 1998, Cancer Res, 58, 1650

Zhou BS, 1998, Clin Exp Metastasis, 16, 43, 10.1023/A:1006559901771

Liu X, 2013, Clin Sci (Lond), 124, 567, 10.1042/CS20120240

Morikawa T, 2010, Hum Pathol, 41, 1742, 10.1016/j.humpath.2010.06.001

Fisher SB, 2013, Cancer, 119, 445, 10.1002/cncr.27619

Morikawa T, 2010, Histopathology, 57, 885, 10.1111/j.1365-2559.2010.03725.x

Duxbury MS, 2007, Biochem Biophys Res Commun, 354, 190, 10.1016/j.bbrc.2006.12.177

Zhang K, 2009, Mol Cancer, 8, 10.1186/1476-4598-8-11

Zhou B, 2001, Cytogenet Cell Genet, 95, 34, 10.1159/000057014

Liu X, 2007, Biochem Pharmacol, 73, 1927, 10.1016/j.bcp.2007.03.014

Ferrandina G, 2010, Cancer Chemother Pharmacol, 65, 679, 10.1007/s00280-009-1073-y

Chen S, 2000, Antisense Nucleic Acid Drug Dev, 10, 111, 10.1089/oli.1.2000.10.111

Zuckerman JE, 2011, J Invest Dermatol, 131, 453, 10.1038/jid.2010.310

Gautam A, 2003, Oncogene, 22, 2135, 10.1038/sj.onc.1206232

10.1200/JCO.2004.12.002

10.1056/NEJMoa065411

Song MS, 2012, Nat Rev Mol Cell Biol, 13, 283, 10.1038/nrm3330

Jordheim LP, 2011, Lancet Oncol, 12, 693, 10.1016/S1470-2045(10)70244-8

10.4161/cbt.20843

Kurata N, 2011, Int J Oncol, 39, 473

Liu X, 2011, Cancer Res, 71, 3202, 10.1158/0008-5472.CAN-11-0054

Liu X, 2006, Clin Cancer Res, 12, 6337, 10.1158/1078-0432.CCR-06-0799

Xue L, 2007, Cancer Res, 67, 16, 10.1158/0008-5472.CAN-06-3200

Okumura H, 2006, Clin Cancer Res, 12, 3740, 10.1158/1078-0432.CCR-05-2416

Matsushita S, 2012, J Dermatol Sci, 68, 19, 10.1016/j.jdermsci.2012.07.005

Cory JG, 1988, Adv Enzyme Regul, 27, 437, 10.1016/0065-2571(88)90030-1

Tsimberidou AM, 2002, Expert Rev Anticancer Ther, 2, 437, 10.1586/14737140.2.4.437

Sampath D, 2003, Oncogene, 22, 9063, 10.1038/sj.onc.1207229

Artin E, 2009, Biochemistry, 48, 11622, 10.1021/bi901590q

Plunkett W, 1995, Semin Oncol, 22, 3

Ruiz van Haperen VW, 1993, Biochem Pharmacol, 46, 762, 10.1016/0006-2952(93)90566-F

Schiller JH, 2002, N Engl J Med, 346, 92, 10.1056/NEJMoa011954

Oettle H, 2007, Jama, 297, 267, 10.1001/jama.297.3.267

von der Maase H, 2005, J Clin Oncol, 23, 4602, 10.1200/JCO.2005.07.757

Bennett CN, 2012, Breast Cancer Res, 14, R109, 10.1186/bcr3230

Odenike OM, 2004, Cancer Chemother Pharmacol, 54, 553, 10.1007/s00280-004-0857-3

10.1006/gyno.1999.5657

10.1016/j.ygyno.2005.09.009

Termrungruanglert W, 2005, Gynecol Oncol, 97, 576, 10.1016/j.ygyno.2005.01.048

Zhou Y, 2002, Mol Pharmacol, 61, 222, 10.1124/mol.61.1.222

Skierski JS, 2005, Acta Pol Pharm, 62, 195

Bendell JC, 2005, Cancer, 103, 1925, 10.1002/cncr.21002

Rodriguez GI, 2002, Clin Cancer Res, 8, 2828

Yamagami K, 1991, Cancer Res, 51, 2319

Masuda N, 2000, Clin Cancer Res, 6, 2288

Shindoh H, 2007, J Toxicol Sci, 32, 343, 10.2131/jts.32.343

Niitsu N, 2001, Cancer Res, 61, 178

Grant S, 1998, Adv Cancer Res, 72, 197, 10.1016/S0065-230X(08)60703-4

Reese ND, 2013, Curr Hematol Malig Rep, 8, 141, 10.1007/s11899-013-0156-3

Fidias P, 1996, Oncologist, 1, 125, 10.1634/theoncologist.1-3-125

Gandhi V, 2002, Clin Pharmacokinet, 41, 93, 10.2165/00003088-200241020-00002

Leoni LM, 1998, Proc Natl Acad Sci USA, 95, 9567, 10.1073/pnas.95.16.9567

Krance RA, 2001, J Clin Oncol, 19, 2804, 10.1200/JCO.2001.19.11.2804

Crews KR, 2002, J Clin Oncol, 20, 4217, 10.1200/JCO.2002.10.006

Robak P, 2013, Cancer Treat Rev

Ghanem H, 2013, Leuk Lymphoma, 54, 688, 10.3109/10428194.2012.726722

Genini D, 2000, Blood, 96, 3537, 10.1182/blood.V96.10.3537

Kantarjian HM, 2003, J Clin Oncol, 21, 1167, 10.1200/JCO.2003.04.031

Pui CH, 2005, Nat Rev Drug Discov, 4, 369, 10.1038/nrd1724

10.1182/blood-2003-06-2122

10.1182/blood-2004-05-1933

Wu X, 2000, Bioorg Med Chem Lett, 10, 2387, 10.1016/S0960-894X(00)00481-9

Witte RS, 1999, Invest New Drugs, 17, 173, 10.1023/A:1006327418043

Chiu CS, 1992, Biochem Cell Biol, 70, 1332, 10.1139/o92-181

10.1586/era.11.175

Shao J, 2006, Mol Cancer Ther, 5, 586, 10.1158/1535-7163.MCT-05-0384

Iyamu WE, 2000, Am J Hematol, 63, 176, 10.1002/(SICI)1096-8652(200004)63:4<176::AID-AJH3>3.0.CO;2-G

10.1081/NCN-200027746

Figul M, 2003, Cancer Chemother Pharmacol, 52, 41, 10.1007/s00280-003-0611-2

Luo J, 2011, Arch Biochem Biophys, 516, 29, 10.1016/j.abb.2011.09.003

Finch RA, 2000, Biochem Pharmacol, 59, 983, 10.1016/S0006-2952(99)00419-0

Aye Y, 2012, J Biol Chem, 287, 35768, 10.1074/jbc.M112.396911

Chaston TB, 2003, Clin Cancer Res, 9, 402

Zhu L, 2009, Biochem Pharmacol, 78, 1178, 10.1016/j.bcp.2009.06.103

Mortazavi A, 2013, Invest New Drugs, 31, 685, 10.1007/s10637-012-9863-1

Kunos C, 2012, J Transl Med, 10, 79, 10.1186/1479-5876-10-79

Martin LK, 2012, Int J Radiat Oncol Biol Phys, 84, e475, 10.1016/j.ijrobp.2012.06.003

10.1667/RR2273.1

Kunos CA, 2009, Radiat Res, 172, 666, 10.1667/RR1858.1

Kunos CA, 2010, Clin Cancer Res, 16, 1298, 10.1158/1078-0432.CCR-09-2469

Kunos CA, 2013, Gynecol Oncol, 130, 75, 10.1016/j.ygyno.2013.04.019

Kunos CA, 2012, Front Oncol, 2, 181, 10.3389/fonc.2012.00181

Tu GC, 2001, Curr Opin Investig Drugs, 2, 1467

Chao J, 2012, Cancer Chemother Pharmacol, 69, 835, 10.1007/s00280-011-1779-5

Lovejoy DB, 2003, Curr Med Chem, 10, 1035, 10.2174/0929867033457557

Cooperman BS, 2005, Adv Enzyme Regul, 45, 112, 10.1016/j.advenzreg.2005.02.012

Lycksell PO, 1994, Biochemistry, 33, 2838, 10.1021/bi00176a013

Lee Y, 2006, Int J Oncol, 28, 469

Cao MY, 2003, Clin Cancer Res, 9, 4553

Ferdinandi ES, 2011, Cancer Chemother Pharmacol, 68, 193, 10.1007/s00280-010-1473-z

Lee Y, 2003, Cancer Res, 63, 2802

Desai AA, 2005, Ann Oncol, 16, 958, 10.1093/annonc/mdi178

Sridhar SS, 2011, Cancer Chemother Pharmacol, 67, 927, 10.1007/s00280-010-1389-7

Lin ZP, 2004, J Biol Chem, 279, 27030, 10.1074/jbc.M402056200

Duxbury MS, 2004, Surgery, 136, 261, 10.1016/j.surg.2004.04.029

Zhang M, 2013, Int J Gynecol Cancer, 23, 659, 10.1097/IGC.0b013e318287e2b3

Rahman MA, 2012, J Control Release, 159, 384, 10.1016/j.jconrel.2012.01.045

Davis ME, 2010, Nature, 464, 1067, 10.1038/nature08956

10.1182/blood-2011-11-382226